Last update 16 Apr 2024

Brazikumab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Anti-IL-23-MAb (Amgen), Brazikumab (USAN/INN), Immunoglobulin g2, anti-(human interleukin 23) (human monoclonal medi2070 heavy chain), disulfide with human monoclonal medi2070 .lambda.-chain, dimer
+ [2]
Target
Mechanism
IL-23 inhibitors(Interleukin-23 inhibitors)
Active Indication-
Originator Organization
Active Organization
Inactive Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

External Link

KEGGWikiATCDrug Bank
D10912--

R&D Status

IndicationHighest PhaseCountry/LocationOrganization
Crohn DiseaseDiscontinuedDE
More
Colitis, UlcerativeDiscontinuedHU
More
PsoriasisPendingAU
More
UlcerPendingPL
More
NeoplasmsPendingES
More
Login to view more data

Clinical Trial Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
121
placebo
(Placebo)
jezbzfefwr(hklhoiqlmz) = himcdmxeth exgjxbjazv (emnvdnoljy, xtgzplmdqs - wuhxcczrrm)
-
06 Mar 2019
(Experimental: MEDI2070 700mg)
jezbzfefwr(hklhoiqlmz) = akymeqjxzx exgjxbjazv (emnvdnoljy, owuiwxvkud - vugkegmizz)
Phase 2
119
syrjnjeimu(toktlmsjzq) = hdutnotzqn vtnvzryxsp (vurzinbmds )
Positive
01 Jul 2017
Placebo
syrjnjeimu(toktlmsjzq) = yhtwuzhwmo vtnvzryxsp (vurzinbmds )
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial Analysis

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free